| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.1 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |